Pharmaceutical Consulting
Data clinic applies biostatistics and the engineering of health informatics with the management of medical information to provide a pharmaceutical and bioengoineering support function related to biostatistics and health information.
We assist in pharmacovigilance by providing both expertise and tooling for the collecting, monitoring, researching, assessing and evaluating information including quality based programme management and biostatistical (reputable) analysis. Pharmacovigilance services can be applied to both drug investigative studies on adverse effects and population trends on nominated cohorts.
Data Clinic can provide biostatistical and health information services to assist with ADR programmes. Most of the studies publish the ADR data which is often analyzed descriptively and do not have a proper control to compare the total number of patients who received a particular medication, thus giving an erroneous value of the study outcome for incidence and magnitude of ADRs. Data Clinic can provide a quality centric approach to your biostatistical needs
We provide discrete and confidential services and analytical programmes can be tailored to demonstrate Benefits, Risk, Harm and Efficacy. We assist pharma and bioengineering organisations by offering assistance with their evidence based programmes including trials and information evidence supporting devices.
Data Clinic can provide data collection and quality measurement for raw data to support medical and pharma research. Data Clinic can provide a rande of advangced biostatistical analysis services in relation to pharma and medical research requirements.
Data Clinic can provide EMR solutions to assist with pharma activities, a base of managing cohorts for broader population studies.
High-level outcome studies can enable administrators to manage chronic diseases by indicators. Once direct data entry by providers of critical information such as medications and immunizations is implemented, an EMR's potential ability to perform any number of outcomes studies will ease the burden of conducting cost analyses and budgetary forecasts.
An EMR powered biostatistical approach to research can provide immense benefits to pharmacovigilance studies and research into adverse drug effects and drug safety.